In ZINC since | Heavy atoms | Benign functionality |
---|---|---|
September 27th, 2005 | 19 | No |
Popular Name: Flutamide Flutamide
Find On: PubMed — Wikipedia — Google
CAS Numbers: 13311-84-7 , [13311-84-7]
.alpha.,.alpha.,.alpha.-Trifluoro-2-methyl-4'-nitro-m-propionotoluidide
13311-84-7; CPD000058187; FLUTAMIDE; SAM002264612
13311-84-7; D00586; Eulexin (TN); Flutamide (JP16/USP/INN)
13311-84-7; Flutamide; Prestwick_228
2-Methyl-N-(4-nitro-3-[trifluoromethyl]phenyl)propanamide
2-Methyl-N-[4-nitro-3-(trifluoromethyl)phenyl]propanamide
2-Methyl-N-[4-nitro-3-(trifluoromethyl)phenyl]propionamide
4'-Nitro-3'-(trifluoromethyl)isobutyranilide
4'-Nitro-3'-trifluoromethylisobutyramilide
4'-Nitro-3'-trifluoromethylisobutyranilide
4-Nitro-3-(trifluoromethyl)isobutyranilide
alpha,alpha,alpha-Trifluoro-2-methyl-4'-nitro-m-propionotoluidide
CPD000058187; FLUTAMIDE; Pamelor; SAM002264612
Eulexin, Flutamin, Drogenil,Flutamide
flutamida; flutamide; flutamidum
m-Propionotoluidide, .alpha.,.alpha.,.alpha.-trifluoro-2-methyl-4'-nitro-
m-Propionotoluidide, 2-methyl-4'-nitro-.alpha.,.alpha.,.alpha.-trifluoro-
m-Propionotoluidide, 2-methyl-4'-nitro-alpha,alpha,alpha-triflouro-
m-Propionotoluidide, alpha,alpha,alpha-trifluoro-2-methyl-4'-nitro-
m-Propionotoluidide, alpha,alpha,alpha-trifluoro-2-methyl-4'-nitro- (8CI)
m-propionotoluidide,alpha,alpha,alpha-trifluoro-2-methyl-4'-nitro
N1-[4-nitro-3-(trifluoromethyl)phenyl]-2-methylpropanamide
Pharmascience Brand of Flutamide
Propanamide, 2-methyl-N-(4-nitro-3-(trifluoromethyl)phenyl)-
Propanamide, 2-methyl-N-[4-nitro-3-(trifluoromethyl)phenyl]-
PUBERTAL FLUTAMIDE STUDY (PUBERTAL STUDIES OF VINCLOZOLIN
Schering Plough Brand of Flutamide
Schering-Plough Brand of Flutamide
Type pH range | xlogP | Des A‑Pol Apolar desolvation (kcal/mol) | Des Pol Polar desolvation (kcal/mol) | H Don H-bond donors | H Acc H-bond acceptors | Chg Net charge | tPSA (Ų) | MWT Molecular weight (g/mol) | RB Rotatable bonds | DL |
---|---|---|---|---|---|---|---|---|---|---|
Ref Reference (pH 7) | 3.02 | 6.33 | -10.97 | 1 | 5 | 0 | 75 | 276.214 | 4 | ↓ |
Note Type | Comments | Provided By |
---|---|---|
MP | 112 | TCI |
ALOGPS_SOLUBILITY | 5.66e-03 g/l | DrugBank-approved |
purity | 9.500000000000000e+001 | Enamine Building Blocks Enamine Building Blocks |
Purity | 98% | APIChem |
UniProt Database Links | AAAD_HUMAN | ChEBI |
Therapy | antiandrogen | SMDC Pharmakon |
therap | antiandrogen, antineoplastic, Nuclear Hormone receptor antagonist | MicroSource Spectrum |
Indications | anticancer, prostate cancer | KeyOrganics Bioactives |
Patent Database Links | EP1438962; EP1506775; EP1537858; EP1538164; EP1550720; EP1580188; EP1611879; EP1717247; EP1719527; EP1728863; EP1738752; EP1738759; EP1772452; EP1803454; EP1813609; EP1832576; EP1900742; EP1938798; EP1988098; EP1990342; US2001020038; US2001027211; US20021 | ChEBI |
PUBCHEM_SUBSTANCE_COMMENT | NCC_SAMPLE_SUPPLIER : LightBiologicals; NCC_SUPPLIER_STRUCTURE_ID : F-262 | NIH Clinical Collection via PubChem |
Target | P450 | Selleck Chemicals |
Indications | prostate cancer | KeyOrganics Bioactives |
PUBCHEM_SUBSTANCE_COMMENT | SAMPLE_SUPPLIER: LightBiologicals; SUPPLIER_STRUCTURE_ID: F-262 | NIH Clinical Collection via PubChem |
Code | Description | Organism Class | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
ANDR-4-E | Androgen Receptor (cluster #4 Of 4), Eukaryotic | Eukaryotes | 3700 | 0.40 | Binding ≤ 10μM |
ANDR-3-E | Androgen Receptor (cluster #3 Of 3), Eukaryotic | Eukaryotes | 580 | 0.46 | Functional ≤ 10μM |
Z81170-1-O | LNCaP (Prostate Carcinoma) (cluster #1 Of 5), Other | Other | 900 | 0.45 | Functional ≤ 10μM |
Uniprot | Swissprot | Description | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
ANDR_HUMAN | P10275 | Androgen Receptor, Human | 154 | 0.50 | Binding ≤ 1μM |
ANDR_HUMAN | P10275 | Androgen Receptor, Human | 1300 | 0.43 | Binding ≤ 10μM |
ANDR_HUMAN | P10275 | Androgen Receptor, Human | 1000 | 0.44 | Functional ≤ 10μM |
Z81170 | Z81170 | LNCaP (Prostate Carcinoma) | 900 | 0.45 | Functional ≤ 10μM |
Description | Species |
---|---|
Nuclear Receptor transcription pathway |